Skip to main content

Nonprofit · EIN 99-3110088

NICK GILBERT NEUROFIBROMATOSIS RESEARCH INSTITUTE

Tax-exempt · DETROIT, MI 48226

Financials

$150K$12024
Revenue Expenses · by fiscal year end
Financials of NICK GILBERT NEUROFIBROMATOSIS RESEARCH INSTITUTE by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990-EZ$150,000$1$149,999$149,999$0$149,999
Financial details: 990-EZ for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$150,000

Expenses

Compensation of officers, directors and key employees
$0
Other expenses
$1

Balance sheet and other

Total assets, start of year
$0
Total assets, end of year
$149,999
Total liabilities, end of year
$0
Net assets, end of year
$149,999
Cash, savings and investments
$149,999
Gross receipts
$150,000

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990-EZ for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensation
LAURA GRANNEMANNPRESIDENT, DIRECTOR0$0
JEFFREY MORGANROTHSECRETARY, DIRECTOR0$0
MATTHEW RIZIKTREASURER, DIRECTOR0$0
DANIEL GILBERTDIRECTOR0$0
JENNIFER GILBERTDIRECTOR0$0

Address and contacts

Address (IRS master file)
1074 WOODWARD AVE, DETROIT, MI 48226-1906
Signed the 990-EZ
MATTHEW J RIZIK, TREASURER
Phone
(313) 373-3977
Return prepared by
PLANTE & MORAN PLLC

Mission

THE PRINCIPAL PURPOSE OF THE INSTITUTE IS TO ACTIVELY AND CONTINUOUSLY ENGAGE DIRECTLY IN THE CONDUCT OF MEDICAL RESEARCH, BOTH ON ITS OWN AND IN CONJUNCTION WITH ONE OR MORE HOSPITALS AND UNIVERSITIES. THE INSTITUTE HAS BEGUN ITS INITIAL EFFORTS IN SCIENTIFIC AND MEDICAL RESEARCH TO ACCELERATE THE DEVELOPMENT OF RESEARCH FINDINGS AND TECHNOLOGIES THAT WILL LEAD TO THE CREATION OF NEW MEDICINES, NEW DIAGNOSTICS, AND OTHER ENABLING PRODUCTS TO TREAT PATIENTS WITH NEUROFIBROMATOSIS ("NF") AND OTHER DEBILITATING NEURONAL DISEASES AND RELATED CONDITIONS. IN THE CURRENT YEAR, THE INSTITUTE HAS ESTABLISHED RESEARCH PARTNERSHIPS AND BEGAN CONSTRUCTION ON ITS OPERATIONAL SPACE.

990-EZ for the year ended December 31, 2024

Program accomplishments

  • THE PRINCIPAL PURPOSE OF THE INSTITUTE IS TO ACTIVELY AND CONTINUOUSLY ENGAGE DIRECTLY IN THE CONDUCT OF MEDICAL RESEARCH, BOTH ON ITS OWN AND IN CONJUNCTION WITH ONE OR MORE HOSPITALS AND UNIVERSITIES. THE INSTITUTE HAS BEGUN ITS INITIAL EFFORTS IN SCIENTIFIC AND MEDICAL RESEARCH TO ACCELERATE THE DEVELOPMENT OF RESEARCH FINDINGS AND TECHNOLOGIES THAT WILL LEAD TO THE CREATION OF NEW MEDICINES, NEW DIAGNOSTICS, AND OTHER ENABLING PRODUCTS TO TREAT PATIENTS WITH NEUROFIBROMATOSIS ("NF") AND OTHER DEBILITATING NEURONAL DISEASES AND RELATED CONDITIONS. IN THE CURRENT YEAR, THE INSTITUTE HAS ESTABLISHED RESEARCH PARTNERSHIPS AND BEGAN CONSTRUCTION ON ITS OPERATIONAL SPACE.

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990-EZ on file
2023December 31, 2023May 15, 2024Check at the IRS

IRS record

EIN
99-3110088
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Hospital or medical research organization
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2025
Accounting year ends
December
Files
Form 990 or 990-EZ
Category (NTEE)
Medical research (H99)
Assets (IRS master file)
$149,999
Income (IRS master file)
$150,000

Filing history

FormYear endedRevenueExpensesAssetsReturn
990-EZDecember 2024$150,000$1$149,999IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 99-3110088).

Questions about NICK GILBERT NEUROFIBROMATOSIS RESEARCH INSTITUTE

What is the EIN of NICK GILBERT NEUROFIBROMATOSIS RESEARCH INSTITUTE?
The employer identification number (EIN) of NICK GILBERT NEUROFIBROMATOSIS RESEARCH INSTITUTE is 99-3110088.
Is NICK GILBERT NEUROFIBROMATOSIS RESEARCH INSTITUTE tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2025.
Are donations to NICK GILBERT NEUROFIBROMATOSIS RESEARCH INSTITUTE tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does NICK GILBERT NEUROFIBROMATOSIS RESEARCH INSTITUTE file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of NICK GILBERT NEUROFIBROMATOSIS RESEARCH INSTITUTE due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did NICK GILBERT NEUROFIBROMATOSIS RESEARCH INSTITUTE last file with the IRS?
The latest return in the IRS public files is the 990-EZ for the year ended December 2024.
Who are the officers and directors of NICK GILBERT NEUROFIBROMATOSIS RESEARCH INSTITUTE?
The 990-EZ for the year ended December 31, 2024 lists 5 people; 0 received compensation from the organization.
How much revenue does NICK GILBERT NEUROFIBROMATOSIS RESEARCH INSTITUTE have?
On its 990-EZ for the year ended December 31, 2024 it reported revenue of $150,000, expenses of $1 and total assets of $149,999 at year end.

Other nonprofits in DETROIT

All nonprofits in DETROIT · Michigan · Medical research